Scotia Capital Inc. Boston Scientific Corp Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

A detailed history of Scotia Capital Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Scotia Capital Inc. holds 15,760 shares of BSX stock, worth $1.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,760

Previous 15,782 0.14%

Holding current value

$1.42 Million

Previous $1.22 Million 8.64%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$72.96 - $84.0 $1,605 - $1,848	-22 Reduced 0.14%	15,760 $1.32 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $605 - $699	9 Added 0.06%	15,782 $1.22 Million
Q1 2024 May 14, 2024	SELL	$57.6 - $68.62 $71,884 - $85,637	-1,248 Reduced 7.33%	15,773 $1.08 Million
Q4 2023 Feb 12, 2024	BUY	$48.64 - $57.81 $341,160 - $405,479	7,014 Added 70.09%	17,021 $983,000
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $652 - $710	-13 Reduced 0.13%	10,007 $528,000
Q1 2023 May 11, 2023	SELL	$45.09 - $50.03 $63,351 - $70,292	-1,405 Reduced 12.3%	10,020 $501,000
Q4 2022 Feb 09, 2023	SELL	$39.56 - $47.22 $171,492 - $204,698	-4,335 Reduced 27.51%	11,425 $528,000
Q3 2022 Nov 10, 2022	BUY	$36.71 - $109.66 $47,539 - $142,009	1,295 Added 8.95%	15,760 $610,000
Q2 2022 Aug 05, 2022	SELL	$35.24 - $47.1 $28,896 - $38,622	-820 Reduced 5.36%	14,465 $539,000
Q1 2022 May 09, 2022	BUY	$40.9 - $45.1 $171,084 - $188,653	4,183 Added 37.68%	15,285 $677,000
Q4 2021 Feb 11, 2022	SELL	$38.07 - $44.87 $1,903 - $2,243	-50 Reduced 0.45%	11,102 $472,000
Q3 2021 Nov 12, 2021	SELL	$41.23 - $45.88 $351,073 - $390,668	-8,515 Reduced 43.3%	11,152 $484,000
Q1 2021 May 06, 2021	BUY	$35.27 - $39.67 $145,241 - $163,361	4,118 Added 26.48%	19,667 $760,000
Q4 2020 Feb 11, 2021	BUY	$33.15 - $41.97 $150,202 - $190,166	4,531 Added 41.12%	15,549 $559,000
Q3 2020 Nov 12, 2020	BUY	$34.44 - $42.23 $379,459 - $465,290	11,018 New	11,018 $421,000
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $615,038 - $1.09 Million	-23,811 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$37.87 - $45.37 $1.19 Million - $1.42 Million	-31,396 Reduced 56.87%	23,811 $1.08 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $198,728 - $214,208	4,930 Added 9.81%	55,207 $2.25 Million
Q2 2019 Aug 13, 2019	BUY	$34.91 - $42.98 $1.34 Million - $1.65 Million	38,470 Added 325.82%	50,277 $2.16 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $150,299 - $186,105	4,567 Added 63.08%	11,807 $453,000
Q4 2018 Feb 11, 2019	BUY	$31.73 - $39.04 $9,519 - $11,712	300 Added 4.32%	7,240 $256,000
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $227,840 - $268,092	6,940 New	6,940 $267,000

Others Institutions Holding BSX

# of Institutions

1,539

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Boston Scientific Corp Transaction History